Investment Analysts’ Upgrades for November 7th (AVDX, CLB, CRL, CRSP, CWAN, DDOG, ESPR, FFIC, GFF, HSIC)

Investment Analysts’ upgrades for Thursday, November 7th:

AvidXchange (NASDAQ:AVDX) was upgraded by analysts at Compass Point from a neutral rating to a buy rating. The firm currently has $15.00 target price on the stock, up from their previous target price of $8.00.

Core Laboratories (NYSE:CLB) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at CLSA from an underperform rating to a hold rating. They currently have $205.00 price target on the stock.

CRISPR Therapeutics (NASDAQ:CRSP) was upgraded by analysts at StockNews.com to a sell rating.

Clearwater Analytics (NYSE:CWAN) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. The firm currently has $33.00 target price on the stock, up from their previous target price of $23.00.

Datadog (NASDAQ:DDOG) was upgraded by analysts at Monness Crespi & Hardt from a neutral rating to a buy rating. They currently have $155.00 price target on the stock.

Esperion Therapeutics (NASDAQ:ESPR) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Flushing Financial (NASDAQ:FFIC) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Griffon (NYSE:GFF) was upgraded by analysts at StockNews.com from a buy rating to a strong-buy rating.

Henry Schein (NASDAQ:HSIC) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

International Flavors & Fragrances (NYSE:IFF) was upgraded by analysts at Vertical Research from a hold rating to a buy rating. Vertical Research currently has $109.00 price target on the stock.

JetBlue Airways (NASDAQ:JBLU) was upgraded by analysts at StockNews.com to a sell rating.

Lincoln National (NYSE:LNC) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

McKesson (NYSE:MCK) was upgraded by analysts at Robert W. Baird from a neutral rating to an outperform rating. They currently have $688.00 target price on the stock, up from their previous target price of $531.00.

Norwegian Cruise Line (NYSE:NCLH) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Peoples Financial Services (NASDAQ:PFIS) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Preformed Line Products (NASDAQ:PLPC) was upgraded by analysts at StockNews.com from a buy rating to a strong-buy rating.

RS Group (LON:RS1) was upgraded by analysts at Shore Capital to a buy rating.

Sanmina (NASDAQ:SANM) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

SBA Communications (NASDAQ:SBAC) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Sinclair (NASDAQ:SBGI) was upgraded by analysts at Wells Fargo & Company from an underweight rating to an equal weight rating. The firm currently has $19.00 target price on the stock, up from their previous target price of $13.00.

Super Group (NYSE:SGHC) was upgraded by analysts at Oppenheimer Holdings Inc. from a market perform rating to an outperform rating. Oppenheimer Holdings Inc. currently has $6.00 target price on the stock.

Schneider National (NYSE:SNDR) was upgraded by analysts at Bank of America Co. from an underperform rating to a buy rating. Bank of America Co. currently has $34.00 target price on the stock, up from their previous target price of $27.00.

Sarepta Therapeutics (NASDAQ:SRPT) was upgraded by analysts at Cantor Fitzgerald from a neutral rating to an overweight rating. They currently have $167.00 price target on the stock, up from their previous price target of $152.00.

Telephone and Data Systems (NYSE:TDS) was upgraded by analysts at Raymond James from a market perform rating to an outperform rating. Raymond James currently has $51.00 target price on the stock.

TriplePoint Venture Growth BDC (NYSE:TPVG) was upgraded by analysts at Keefe, Bruyette & Woods from an underperform rating to a market perform rating. Keefe, Bruyette & Woods currently has $7.50 price target on the stock, down from their previous price target of $8.00.

United States Cellular (NYSE:USM) was upgraded by analysts at Raymond James from a market perform rating to an outperform rating. They currently have $86.00 price target on the stock.

Zymeworks (NYSE:ZYME) was upgraded by analysts at Leerink Partners from a market perform rating to an outperform rating. They currently have $25.00 target price on the stock, up from their previous target price of $10.00.